Research analysts at Jefferies Group (NYSE: JEF) raised their price target on shares of Amylin Pharma (NASDAQ: AMLN) to $30.00 in a report issued on Tuesday.
Separately, analysts at Imperial Capital cut their price target on shares of Amylin Pharma to $7.50 in a research note to investors on Monday. Analysts at Goldman Sachs (NYSE: GS) reiterated a “sell” rating on shares of Amylin Pharma in a research note to investors on Monday, January 30th. Also, analysts at Piper Jaffray (NYSE: PJC) reiterated an “overweight” rating on shares of Amylin Pharma in a research note to investors on Monday, January 30th. They now have a $17.00 price target on the stock.
Amylin Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Its wholly owned subsidiaries are Amylin Ohio, LLC, and Amylin Investments, LLC. It is marketing two medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection and it is seeking approval for BYDUREON (exenatide extended-release for injectable suspension), an investigational sustained-release medication for type-II diabetes, which is administered only once a week. It is focused on making prudent investment decisions based on positive clinical data to advance its obesity program, including the development of pramlintide/ metreleptin, a combination therapy for the treatment of obesity, which the Company and its obesity partner, Takeda Pharmaceutical Company Limited (Takeda), is advancing toward phase-III development.
Amylin Pharma opened at 16.68 on Tuesday. Amylin Pharma has a 52-week low of $8.03 and a 52-week high of $18.30. The stock has a 50-day moving average of $12.1 and a 200-day moving average of $10.96. The company’s market cap is $2.440 billion.
Stay on top of analysts' coverage with our daily email newsletter that provides a concise list of analysts' upgrades, analysts' downgrades and analysts' price target changes for each day. Click here to register.